DekaBank Deutsche Girozentrale’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-39,000
Closed -$172K 1107
2016
Q1
$172K Sell
39,000
-2,500
-6% -$10K ﹤0.01% 873
2015
Q4
$217K Buy
41,500
+1,000
+2% +$5.8K ﹤0.01% 852
2015
Q3
$245K Buy
40,500
+2,200
+6% +$27K ﹤0.01% 826
2015
Q2
$605K Buy
38,300
+6,000
+19% +$72.9K 0.01% 667
2015
Q1
$351K Sell
32,300
-1,400
-4% -$14.3K ﹤0.01% 794
2014
Q4
$354K Sell
33,700
-3,000
-8% -$29.3K ﹤0.01% 762
2014
Q3
$352K Buy
36,700
+1,000
+3% +$10.2K ﹤0.01% 733
2014
Q2
$412K Sell
35,700
-500
-1% -$4.55K 0.01% 643
2014
Q1
$362K Buy
36,200
+2,200
+6% +$31.8K 0.01% 631
2013
Q4
$475K Buy
34,000
+3,000
+10% +$41.3K 0.01% 554
2013
Q3
$463K Buy
31,000
+3,500
+13% +$41.9K 0.01% 559
2013
Q2
$258K Buy
+27,500
New +$186K 0.01% 502

Other funds holding RPTP

DekaBank Deutsche Girozentrale's RPTP Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2016, closing a stake of 39,000 shares — an estimated $172K sold.

DekaBank Deutsche Girozentrale first reported a position in RPTP in Q2 2013 and held it in 12 quarters. The position peaked at $605K in Q2 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 39,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2016, an estimated $172K.
  • DekaBank Deutsche Girozentrale first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $605K in Q2 2015.
  • 93 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.